Nominees for the
Most Innovative Product Award
The European Pressure Ulcer Advisory Panel (EPUAP) is proud to introduce the Most Innovative Product Award at the EPUAP 2024 Conference. This award aims to recognise and celebrate outstanding innovation within the field of pressure ulcer prevention and treatment. By encouraging exhibitors and sponsors to present their innovative products, we aim to foster collaboration, inspire creativity, and drive advancements in patient care.
Purpose: The award aims to recognize outstanding innovation in pressure ulcer prevention and treatment, fostering collaboration and driving advancements in patient care.
Eligibility: All exhibitors and sponsors of the EPUAP 2024 Conference, regardless of company size, are eligible to participate.
Submission Process: Exhibitors must submit their product before the submission deadline 10 July 2024, providing comprehensive information about its features, benefits, and innovative aspects.
Criteria: Products will be evaluated based on innovation, evidence and effectiveness, creativity, potential and scalability, and presentation and demonstration.
Presentation and Demonstration: The product should have a clear and attractive presentation at the exhibition, using visuals, videos, models, or samples to communicate its value proposition and competitive advantage persuasively.
Voting Procedure: Attendees of the EPUAP 2024 Conference will have the opportunity to vote for the most innovative product through the conference app. To cast their vote, attendees must visit each exhibitor’s booth to learn about the products on display.
Care of Sweden AB
CuroCell iA®
Released on 1 September 2023
Available in Europe, Australia, and New Zealand
CuroCell iA®, our innovative aid for pressure ulcer prevention and treatment stands out due to its advanced technological features and patient-centred design. Innovative algorithm CuroCell iA® utilizes algorithms that monitors and adjusts the air pressure in the support surface based on the individual’s body and movements. This patient-specific approach is developed to ensure optimal airflow and pressure relief across all cells at all times, significantly reducing the risk of pressure ulcers. Proven development and efficacy Developed through continuous innovation since 2009, our efforts culminated in the creation of the Pulsating Mode™ in 2018. In clinical studies, the Pulsating Mode™ demonstrated great results, achieving healing of existing pressure ulcers within 30 days. Building on this success, we have developed Gentle Alternating Low Pressure, to be a more efficient alternative to traditional alternating pressure mattresses, offered at an attractive price point. Autonomous adjustments CuroCell iA® features autonomous adjustment capabilities. It is developed with software that, using artificial intelligence (AI) and built-in sensors, constantly monitors the individual’s contact with the support surface and calculates its response. The system identifies the individual’s weight and height and can detect changes, such as when the individual adopts a new position. When the system senses the individual’s body and movements, it adjusts the internal air pressure accordingly, ensuring that the comfort settings are appropriately set for the individual. For more mobile individuals, they can move freely in bed without the pressure getting too high or too low, as the internal pressure adjusts to their movements. This dynamic adjustment is developed to achieve enhanced comfort and a reduced incidence of pressure ulcer. Grip-lock feature The support surfaces feature a Grip-lock cover that simplifies handling, addressing the challenge of managing medical equipment. The high friction surface keeps the support surface securely in place without the need for manual attachment with straps. This design is developed to ensure ease of use for healthcare providers and enhance patient care efficiency. Advanced compressor design Our technical compressor design reduces the need for maintenance, contributing to the sustainability of urban communities in alignment with the United Nations Sustainable Development Goals. By reducing the time spent on medical device management, healthcare professionals can dedicate more time to patient care, addressing the growing demands of an aging population and diverse healthcare needs.
Available material: Attachment 1
CEUMED Medical Devices LLP
EVA TILT®
Released on 30 January 2024
Available in India and United Arab Emirates
EVA TILT® is a revolutionary innovation that nurses and caregivers have long awaited. This advanced support surface combines pressure redistribution and patient repositioning in a single unit. It automatically shifts pressure points every five minutes and gently tilts up to 30 degrees over a 15-minute period, achieving complete repositioning within an hour. This ensures optimal pressure relief and compliant patient repositioning. What makes EVA TILT truly unique is its dual functionality: changing pressure points every five minutes and achieving full repositioning every 30 minutes. This innovative approach provides a higher level of pressure relief and redistribution, surpassing traditional alternating pressure mattresses and significantly elevating the standard of patient care. Additionally, EVA TILT is cost-effective, offering an affordable pressure-relieving and repositioning system not currently available in the market. Our goal is to make this innovative product accessible to every hospital and home care setting, ensuring convenience and ease of access for patients.
Available material: Attachment 1
LIGAMED medical Produkte GmbH
LIGASANO® Trapeze Cushion Dressing
Released on 1 June 2022
Available in Europe
Due to the increased number of prone positions for ventilated patients during the COVID pandemic, a patient-specific option for stabilisation and pressure reduction could be offered, which is successfully used in many intensive care units. The LIGASANO® trapeze cushion dressing made of LIGASANO® orange, is used primarily in intensive care, especially for ventilated patients in the prone position. This padded dressing enables very stable positioning of the head without losing sight of the patient’s face. The tube or tracheal cannula can be monitored at all times and corrected if necessary. Mouth and nose care is also possible without any problems. The trapezoidal shape and the option of height adjustment prevent the neck from being hyperextended.
Available material: Attachment 1
medicalsol
Debrichem
Released on 4 February 2021
Available in Australia, Austria, Brazil, Finland, France, Germany, Italy, Malaysia, Norway, Saudi Arabia, Sweden, Switzerland, Turkey, UK
Debrichem: Revolutionary Technology in Wound Management Effective Chemical Debridement in 60 Seconds Debrichem offers a unique solution for wound management. Through chemical debridement, wound coatings and infections in the wound area are efficiently removed within just 60 seconds. Effectiveness and Efficiency The rapid and effective reduction of infections in the wound area promotes wound healing and minimizes side effects. Thus, Debrichem significantly contributes to a faster healing process. User-Friendliness Debrichem is extremely user-friendly. With an application time of only 60 seconds, it enables quick and effective debridement that can be seamlessly integrated into everyday medical care. Economic Benefits Debrichem also offers substantial economic benefits. By shortening the healing time and reducing the number of necessary treatments, it contributes to cost efficiency and significantly lowers the overall costs of wound care.
Available material: Attachment 1
MICRO-MEDICAL AG
Myriad Matrix
Released on 30 May 2024
Available in Switzerland, USA, 30 other countries
Surgeons are inherently creative people, that have to look for ingenious solutions during stressful moments in surgery. When it comes to wounds, this often involves where to get the tissue correct the soft tissue defects. Myriad Matrix is an implant, derived from Ovine Forestomach, that provides structure and biology to enable the fast generation of the body’s own tissue and provides a solution for surgeons in this stressful situations.
Available material: Attachment 1
Piomic Medical AG
COMS One Therapy System
Released on 1 November 2021
Available in Europe
COMS One therapy delivers concurrent optical and magnetic stimulation (COMS) to enhance cellular respiration and ATP production, while modulating inflammation. COMS was initially cleared in the EU for treatment of chronic foot and leg ulcers, but its synergistic biologic mechanisms are clinically relevant for the treatment of pressure ulcers as well. Early case series results, to be presented at this year’s EPUAP conference, illustrate the promise that COMS holds for the treatment of chronic and refractory pressure ulcers, including severe Stage 3 and 4 ulcers. When used as an adjunct to standard of care, COMS was able to achieve impressive healing outcomes in patients who had previously shown little to no progress with other advanced therapies. Given the significant and disproportionate contribution of chronic ulcers to rising healthcare costs and mortality rates, innovation is greatly needed to provide caregivers with novel tools to improve outcomes and lower costs. These initial case series results from the adjunctive use of COMS in severe pressure ulcers are exciting and support further study of COMS One therapy in chronic wounds of various etiologies.
Available material: Attachment 1, Attachment 2, Attachment 3
PU sensor AB
PU sensor
Released on 2 February 2021
Available in The Nordics and EU (Germany, Czech Republic, Slovenia, Italy and Cyprus), Hong Kong, Japan, Australia, New Zealand, and United Arab Emirates
PU sensor revolutionizes pressure ulcer risk assessment with a combination of optical and temperature sensors, providing precise evaluations through a machine learning-based algorithm. This innovation allows for quick and objective risk assessments in just minutes, potentially improving patient care significantly compared to current subjective methods.
Available material: Attachment 1
ServiceMed srl
Flow Air
Released on 1 June 2024
Available in Italy
Flow Air is an active true-air-loss pressure redistribution system capable of meeting any needs in terms of prevention and treatment of pressure injuries and skin maceration. Thanks to its high technological and innovative content, it represents a unique element of discontinuity in the anti-decubitus landscape. Key features: • True Air Loss with static, dynamic, immersion and high-frequency alternating cycle (wave) treatments • Inflation unit with Dual-Drive technology to offer virtually infinite treatment possibilities while minimizing noise and maximizing power efficiency. • Cloud-Enabled for remote monitoring of treatment data, events, and alarms. • Cover with hydrophilic surface treatment Quick-Dry-Frame (QDF) and 20 um microporous membrane to maximize breathability and vapor permeability. • Air surface with Silent-Flow lateral air loss system. • Full-Immersion heel zone. • Antimicrobial treatment and graphical interface with 3.5” display with autolock and automatic night mode.
Available material: Attachment 1
